EP 2027106 A2 20090225 - CGRP RECEPTOR ANTAGONISTS
Title (en)
CGRP RECEPTOR ANTAGONISTS
Title (de)
CGRP-REZEPTORANTAGONISTEN
Title (fr)
ANTAGONISTES DU RÉCEPTEUR DU CGRP
Publication
Application
Priority
- US 2007013896 W 20070613
- US 81317806 P 20060613
Abstract (en)
[origin: WO2007146349A2] The present invention relates to CGRP receptor antagonists, pharmaceutical compositions thereof, and methods therewith for treating CGRP receptor-mediated diseases and conditions.
IPC 8 full level
C07D 401/00 (2006.01)
CPC (source: EP)
A61P 1/04 (2017.12); A61P 3/10 (2017.12); A61P 9/10 (2017.12); A61P 11/06 (2017.12); A61P 11/08 (2017.12); A61P 13/10 (2017.12); A61P 17/00 (2017.12); A61P 19/02 (2017.12); A61P 25/00 (2017.12); A61P 25/06 (2017.12); A61P 25/08 (2017.12); A61P 25/36 (2017.12); A61P 27/16 (2017.12); A61P 29/00 (2017.12); A61P 31/04 (2017.12); A61P 37/08 (2017.12); A61P 43/00 (2017.12); C07D 277/14 (2013.01); C07D 417/06 (2013.01); C07D 417/14 (2013.01); C07D 471/04 (2013.01); C07D 471/10 (2013.01); C07D 498/10 (2013.01); C07D 513/10 (2013.01)
Citation (search report)
See references of WO 2007146349A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA HR MK RS
DOCDB simple family (publication)
WO 2007146349 A2 20071221; WO 2007146349 A3 20080925; AR 061362 A1 20080820; AU 2007258294 A1 20071221; CA 2655085 A1 20071221; CN 101501009 A 20090805; EP 2027106 A2 20090225; IL 195807 A0 20090901; JP 2009539997 A 20091119; JP 5382799 B2 20140108; MX 2008015906 A 20090306; NZ 574097 A 20120112; TW 200813019 A 20080316; ZA 200810791 B 20100331
DOCDB simple family (application)
US 2007013896 W 20070613; AR P070102587 A 20070613; AU 2007258294 A 20070613; CA 2655085 A 20070613; CN 200780029737 A 20070613; EP 07796082 A 20070613; IL 19580708 A 20081209; JP 2009515476 A 20070613; MX 2008015906 A 20070613; NZ 57409707 A 20070613; TW 96121362 A 20070613; ZA 200810791 A 20070613